We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
New Journal Dedicated to Clinical Investigation
News

New Journal Dedicated to Clinical Investigation

New Journal Dedicated to Clinical Investigation
News

New Journal Dedicated to Clinical Investigation

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "New Journal Dedicated to Clinical Investigation"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Clinical Investigation is dedicated to systematic coverage of the methodology, progress and outcomes of clinical trials. As a peer-reviewed, monthly publication Clinical Investigation provides a forum for the rapid publication of original research and critically reviews the latest developments in medical research, from Phase I trials through to post-marketing studies and pharmacoeconomic research.

Clinical Investigation assimilates the wealth of information resulting from the clinical development of new medicines into concise yet comprehensive formats. The journal addresses contemporary issues in clinical drug development and methodology, and also provides a platform for the rapid publication of new drug data from human studies. Coverage spans all therapeutic areas and relates to conventional small-molecule drugs as well as biotech-derived therapeutic entities, including vaccines, monoclonal antibodies, antisense, cell and gene therapies and recombinant proteins. The journal publishes review articles, original papers, perspectives, commentaries, meeting reports, news, views and more.

Clinical Investigation provides a systematic program of peer-reviewed coverage relating to the clinical evaluation of new and established therapies. The audience for Clinical Investigation includes clinical investigators, healthcare decision makers, formulary managers, clinicians, regulatory personnel and medical affairs professionals.

Prof. E. Michael Lewiecki, Senior Editor is responsible for the editorial direction of Clinical Investigation, and supported by a team of Associate Editors and experts making up the international Editorial Advisory board.

Senior Editor Lewiecki commented, “Clinical Investigation is an excellent addition to the Future Science journal collection, Clinical Investigation fulfils an unmet need in providing critical review of objectives and outcomes of clinical trials.”

He stated, “…I have no doubt that Clinical Investigation will become a go-to-source for timely and authoritative discussion regarding clinical research.”

Further information on Clinical Investigation can be found in the Journals section of the Pharma Outsourcing web community.

Advertisement